Table 2 Serum ALT, AST and GGT levels in patients with chronic hepatitis C after treatment with UDCA
Dose (mg/day)Pre-treatment,mean±SDPost-treatment,mean±SDChange (%),median (range)
ALT (IU/l)150109.2±49.795.8±60.2−15.3 (−80.7 to +375.9)
600106.3±59.475.7±41.9−29.2 (−88.3 to +95.2)
900110.6±57.381.3±90.5−36.2 (−81.4 to +1696.9)
AST (IU/l)15084.0±39.175.5±43.6−13.6 (−74.2 to +347.2)
60082.4±41.863.1±32.9−25.0 (−82.7 to +72.5)
90085.2±45.065.5±49.6−29.8 (−79.0 to +1026.1)
GGT (IU/l)15087.5±73.070.4±58.3−22.4 (−74.6 to +145.9)
60082.4±62.249.7±43.0−41.0 (−81.1 to +153.1)
90085.9±66.343.8±44.8−50.0 (−80.1 to +213.9)